# Neurocrine Biosciences (NBIX) — News

NBIX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/nbix/news

## Recent headlines

- [Neurocrine Biosciences, Inc.: BMO cuts target price to $150 from $164](https://www.ainvest.com/news/neurocrine-biosciences-bmo-cuts-target-price-150-164-2610) — AInvest Wire, Oct 12, 2026
  On October 12, 2026, BMO lowered its price target for Neurocrine Biosciences, Inc. (NASDAQ: NBIX) to $150 from $164, reflecting a more cautious outlook on the biotechnology company’s near-term prospects. This adjustment follows a broader trend of analyst revisions, with three major firms reducing…
- [Neurocrine Biosciences appoints Eiry W. Roberts, M.D., as chief medical officer](https://www.ainvest.com/news/neurocrine-biosciences-appoints-eiry-roberts-chief-medical-officer-2609) — AInvest Wire, Sep 28, 2026
- [Neurocrine Biosciences, Inc.: RBC cuts target price to $187 from $198](https://www.ainvest.com/news/neurocrine-biosciences-rbc-cuts-target-price-187-198-2609) — AInvest Wire, Sep 21, 2026
  Neurocrine Biosciences, Inc. (NASDAQ: NBIX) has seen recent analyst activity that reflects evolving expectations for the company’s stock. On May 29, 2026, RBC Capital adjusted its price target for Neurocrine from $180 to $183, while maintaining an Outperform rating . More recently, however, RBC has…
- [Neurocrine Biosciences Inc: Morgan Stanley raises target price to $183.00 from $182.00](https://www.ainvest.com/news/neurocrine-biosciences-morgan-stanley-raises-target-price-183-00-182-00-2609) — AInvest Wire, Sep 11, 2026
- [Neurocrine Biosciences, Inc.: Citigroup raises target price to $253 from $249](https://www.ainvest.com/news/neurocrine-biosciences-citigroup-raises-target-price-253-249-2609) — AInvest Wire, Sep 3, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).